{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,10]],"date-time":"2026-10-10T21:59:09Z","timestamp":1791669549790,"version":"4.3.4"},"reference-count":42,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2020,11,11]],"date-time":"2020-11-11T00:00:00Z","timestamp":1605052800000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"},{"start":{"date-parts":[[2020,11,11]],"date-time":"2020-11-11T00:00:00Z","timestamp":1605052800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"name":"Key Research & Development Projects of Shaanxi Province, China","award":["2017SF-336 and 2019SF-163"],"award-info":[{"award-number":["2017SF-336 and 2019SF-163"]}]},{"name":"Education Department Special Scientific Research Projects of Shaanxi Province, China","award":["20JC031"],"award-info":[{"award-number":["20JC031"]}]},{"name":"the National Science and Technology Major Project of China","award":["2018ZX09101003001-017"],"award-info":[{"award-number":["2018ZX09101003001-017"]}]},{"DOI":"10.13039\/501100001809","name":"the National Natural Science Foundation of China","doi-asserted-by":"crossref","award":["81973411"],"award-info":[{"award-number":["81973411"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Infect Dis"],"published-print":{"date-parts":[[2020,12]]},"abstract":"<jats:title>Abstract<\/jats:title>\n<jats:sec>\n<jats:title>Background<\/jats:title>\n<jats:p>Carvacrol, as the major components of aromatic plants used for treating human skin diseases including origanum, Satureja, thymus, and coridothymus species, presented a kind of antiviral activity. To explore the mechanisms of carvacrol against herpes simplex virus (HSV) in vitro.<\/jats:p>\n<\/jats:sec>\n<jats:sec>\n<jats:title>Method<\/jats:title>\n<jats:p>The BSC-1 cells model of HSV infection was established, and from the two aspects of viral replication level and cell death pathway, the antiviral effects of carvacrol on HSV infected cells were also evaluated by plaque assay under the three modes including prevention, treatment, and direct inactivation.<\/jats:p>\n<\/jats:sec>\n<jats:sec>\n<jats:title>Results<\/jats:title>\n<jats:p>In the three ways, the half-maximal effective concentration (EC<jats:sub>50<\/jats:sub>) of 2% true carvacrol solution on HSV-2 infected cells were severally 0.43, 0.19 and 0.51\u2009mmol\/L, and the corresponding therapeutic index (TI) were 4.02, 9.11 and 3.39, respectively. It\u2019s the opposite of the increased levels caused by HSV-2 infection, that both the expressions at the transcription genes and protein levels of virus own replication key factors (including ICP4, ICP27, VP16, gB, and UL30) and cytokines (including RIP3, TNF-\u03b1, and MLKL) of infected cells treated with carvacrol were dose-dependently inhibited. Besides, HSV-2 infection can cause the decrease of intracellular protein ubiquitination level, and carvacrol can reverse the ubiquitination decrease level caused by HSV-2 infection.<\/jats:p>\n<\/jats:sec>\n<jats:sec>\n<jats:title>Conclusion<\/jats:title>\n<jats:p>Carvacrol exhibits significant antiviral activity by inhibiting the HSV-2 proliferation process and HSV-2-induced TNF-\u03b1 increasing levels, decreasing RIP3 and MLKL protein expressions through the intracellular RIP3-mediated programmed cell necrosis pathway. In addition, carvacrol also may exhibit anti-HSV-2 activity by reversing the ubiquitination decrease level caused by HSV-2 infection on the ubiquitin-proteasome system, which provides insights into the molecular mechanism.<\/jats:p>\n<\/jats:sec>","DOI":"10.1186\/s12879-020-05556-9","type":"journal-article","created":{"date-parts":[[2020,11,11]],"date-time":"2020-11-11T13:03:03Z","timestamp":1605099783000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":29,"title":["Antiviral mechanism of carvacrol on HSV-2 infectivity through inhibition of RIP3-mediated programmed cell necrosis pathway and ubiquitin-proteasome system in BSC-1 cells"],"prefix":"10.1186","volume":"20","author":[{"given":"Li","family":"Wang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dan","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xingan","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rui","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yunlan","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2020,11,11]]},"reference":[{"key":"5556_CR1","first-page":"101","volume-title":"Clinical virology","author":"ZQ Yang","year":"2000","unstructured":"Yang ZQ, Yu H. Clinical virology. Beijing: China Medical Science and Technology Press; 2000. p. 101\u201312."},{"issue":"1","key":"5556_CR2","doi-asserted-by":"publisher","first-page":"e33","DOI":"10.1055\/s-0038-1635100","volume":"8","author":"CM Drumm","year":"2018","unstructured":"Drumm CM, Caufield MC, DeKlotz CM. Intrauterine herpes simplex virus infection presenting as a Zosteriform eruption in a newborn. AJP Rep. 2018;8(1):e33\u20136. https:\/\/doi.org\/10.1055\/s-0038-1635100.","journal-title":"AJP Rep"},{"issue":"10","key":"5556_CR3","first-page":"25","volume":"23","author":"LS Goettsche","year":"2017","unstructured":"Goettsche LS, Wanat KA. Undisturbed characteristic herpes simplex virus 2 outbreak. Dermatol Online. 2017;23(10):25\u20136 13030\/qt6jb4q498.","journal-title":"Dermatol Online"},{"key":"5556_CR4","doi-asserted-by":"publisher","first-page":"16","DOI":"10.1136\/sti.2006.020966","volume":"83","author":"G Paz-Bailey","year":"2007","unstructured":"Paz-Bailey G, Ramaswamy M, Hawkes SJ. Herpes simplex virus type 2: epidemiology and management options in developing countries. Sex Transm Infect. 2007;83:16\u201322. https:\/\/doi.org\/10.1136\/sti.2006.020966.","journal-title":"Sex Transm Infect"},{"key":"5556_CR5","doi-asserted-by":"publisher","first-page":"S3","DOI":"10.1086\/343739","volume":"186","author":"JS Smith","year":"2002","unstructured":"Smith JS, Robinson NJ. Age-specific prevalence of infection with herpes simplex virus types 2 and 1: a global review. J Infect Dis. 2002;186:S3\u201328. https:\/\/doi.org\/10.1086\/343739.","journal-title":"J Infect Dis"},{"key":"5556_CR6","doi-asserted-by":"publisher","first-page":"271","DOI":"10.1053\/j.spid.2005.06.007","volume":"16","author":"DW Kimberlin","year":"2005","unstructured":"Kimberlin DW. Herpes simplex virus infections in neonates and early childhood. Semin Pediatr Infect Dis. 2005;16:271\u201381. https:\/\/doi.org\/10.1053\/j.spid.2005.06.007.","journal-title":"Semin Pediatr Infect Dis"},{"issue":"5","key":"5556_CR7","doi-asserted-by":"publisher","first-page":"448","DOI":"10.1016\/j.survophthal","volume":"57","author":"AV Farooq","year":"2012","unstructured":"Farooq AV, Shukla D. Herpes simplex epithelial and stromal keratitis: an epidemiologic update. Surv Ophthalmol. 2012;57(5):448\u201362. https:\/\/doi.org\/10.1016\/j.survophthal 2012.01.005.","journal-title":"Surv Ophthalmol"},{"key":"5556_CR8","first-page":"753","volume":"18","author":"J Li","year":"2012","unstructured":"Li J, Peng F. Research progress of traditional Chinese medicine on anti-herpes simplex virus. Med Recapitulate. 2012;18:753\u20135 https:\/\/doi.org\/CNKI:SUN:YXZS.0.2012-05-039.","journal-title":"Med Recapitulate"},{"key":"5556_CR9","doi-asserted-by":"publisher","first-page":"261","DOI":"10.1016\/s1386-6532(00)00169-4","volume":"21","author":"HJ Fiele","year":"2001","unstructured":"Fiele HJ. Herpes simplex antiviral drug resistance-current trends and future prospects. J Clin Virol. 2001;21:261\u20139. https:\/\/doi.org\/10.1016\/s1386-6532(00)00169-4.","journal-title":"J Clin Virol"},{"key":"5556_CR10","doi-asserted-by":"publisher","first-page":"186","DOI":"10.1007\/978-1-4939-0694-9_7","volume":"24","author":"J Piret","year":"2014","unstructured":"Piret J, Drouot E, Boivin G. Antiviral drug resistance in herpes viruses. Rev Med Virol. 2014;24:186\u2013218. https:\/\/doi.org\/10.1007\/978-1-4939-0694-9_7.","journal-title":"Rev Med Virol"},{"key":"5556_CR11","first-page":"740","volume":"36","author":"CL Ventola","year":"2011","unstructured":"Ventola CL. The drug shortage crisis in the United States: causes, impact, and management strategies. P T. 2011;36:740\u201357 PMCID: PMC 3278171.","journal-title":"P T"},{"key":"5556_CR12","doi-asserted-by":"publisher","first-page":"237","DOI":"10.1007\/s11010-018-3329-5","volume":"448","author":"GB Ayse","year":"2018","unstructured":"Ayse GB, Abdurrahim K, Eray MG. Effects of carvacrol on human ibroblast (WS-1) and gastric adenocarcinoma (AGS) cells in vitro and on Wistar rats in vivo. Mol Cell Biochem. 2018;448:237\u201349. https:\/\/doi.org\/10.1007\/s11010-018-3329-5.","journal-title":"Mol Cell Biochem"},{"key":"5556_CR13","doi-asserted-by":"publisher","first-page":"72","DOI":"10.1016\/j.ijfoodmicro.2014.09.028","volume":"192","author":"C Sanchez","year":"2015","unstructured":"Sanchez C, Aznar R, Sanchez G. The effect of carvacrol on enteric viruses. Int J Food Microbiol. 2015;192:72\u20136. https:\/\/doi.org\/10.1016\/j.ijfoodmicro.2014.09.028.","journal-title":"Int J Food Microbiol"},{"key":"5556_CR14","doi-asserted-by":"publisher","first-page":"1149","DOI":"10.1111\/jam.12453","volume":"116","author":"DH Gilling","year":"2014","unstructured":"Gilling DH, Kitajima M, Torrey JR. Antiviral efficacy and mechanisms of action of oregano essential oil and its primary component carvacrol against murine norovirus. J Appl Microbiol. 2014;116:1149\u201363. https:\/\/doi.org\/10.1111\/jam.12453.","journal-title":"J Appl Microbiol"},{"key":"5556_CR15","doi-asserted-by":"publisher","first-page":"1616","DOI":"10.1590\/S1517-838220110004000049","volume":"42","author":"MR Pilau","year":"2011","unstructured":"Pilau MR, Alves SH, Weiblen R. Antiviral activity of the Lippia graveolens (Mexican oregano) essential oil and its main compound carvacrol against human and animal viruses. Braz J Microbiol. 2011;42:1616\u2013124. https:\/\/doi.org\/10.1590\/S1517-838220110004000049.","journal-title":"Braz J Microbiol"},{"key":"5556_CR16","doi-asserted-by":"publisher","first-page":"156","DOI":"10.1016\/j.micpath.2017.09.057","volume":"112","author":"H Miladi","year":"2017","unstructured":"Miladi H, Zmantar T, Kouidhi B. Synergistic effect of eugenol, carvacrol, thymol, p-cymene and \u03b3-terpinene on inhibition of drug resistance and biofilm formation of oral bacteria. Microb Pathog. 2017;112:156\u201363. https:\/\/doi.org\/10.1016\/j.micpath.2017.09.057.","journal-title":"Microb Pathog"},{"key":"5556_CR17","doi-asserted-by":"publisher","first-page":"73","DOI":"10.1016\/j.micpath.2017.09.057","volume":"4","author":"X Han","year":"2017","unstructured":"Han X, Parker TL. Anti-inflammatory, tissue remodeling, immunomodulatory, and anticancer activities of oregano (Origanum vulgare) essential oil in a human skin disease mode. Biochim Open. 2017;4:73\u20137. https:\/\/doi.org\/10.1016\/j.micpath.2017.09.057.","journal-title":"Biochim Open"},{"key":"5556_CR18","doi-asserted-by":"publisher","first-page":"656","DOI":"10.1016\/j.biopha.2017.12.060","volume":"98","author":"H Ozturk","year":"2018","unstructured":"Ozturk H, Cetinkaya A, Duzcu SE. Carvacrol attenuates histopathogic and functional impairments induced by bilateral renal ischemia\/reperfusion in rats. Biomed Pharmacother. 2018;98:656\u201361. https:\/\/doi.org\/10.1016\/j.biopha.2017.12.060.","journal-title":"Biomed Pharmacother"},{"key":"5556_CR19","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1080\/01480545.2018.1538233","volume":"29","author":"G Vahideh","year":"2018","unstructured":"Vahideh G, Azam A, Omid R, Amir HM, Mohammad HB. Safety and tolerability of carvacrol in healthy subjects: a phase I clinical study. Drug Chem Toxicol. 2018;29:1\u201312. https:\/\/doi.org\/10.1080\/01480545.2018.1538233.","journal-title":"Drug Chem Toxicol"},{"key":"5556_CR20","doi-asserted-by":"publisher","first-page":"151","DOI":"10.1002\/ptr.5967","volume":"32","author":"A Azam","year":"2018","unstructured":"Azam A, Mohammad RK, Mohammad HB. Possible therapeutic effect of carvacrol on asthmatic patients: a randomized, double blind, placebo - controlled, phase II clinical trial. Phytother Res. 2018;32:151\u20139. https:\/\/doi.org\/10.1002\/ptr.5967.","journal-title":"Phytother Res"},{"key":"5556_CR21","doi-asserted-by":"publisher","first-page":"42","DOI":"10.14715\/cmb\/2017.63.8.10","volume":"63","author":"J Sharifi-Rad","year":"2017","unstructured":"Sharifi-Rad J, Salehi B, Schnitzler P, Ayatollahi S, Kobarfard F, Fathi M, et al. Susceptibility of herpes simplex virus type 1 to monoterpenes thymol, carvacrol, p-cymene and essential oils of Sinapis arvensis L., Lallemantia royleana Benth. And Pulicaria vulgaris Gaertn. Cell Mol Biol (Noisy-le-Grand, France). 2017;63:42\u20137. https:\/\/doi.org\/10.14715\/cmb\/2017.63.8.10.","journal-title":"Cell Mol Biol (Noisy-le-Grand, France)"},{"key":"5556_CR22","doi-asserted-by":"publisher","first-page":"1555","DOI":"10.1002\/ptr.6084","volume":"32","author":"MM Toujani","year":"2018","unstructured":"Toujani MM, Ritt\u00e0 M, Civra A, Genovese S, Epifano F, Ghram A, et al. Inhibition of HSV-2 infection by pure compounds from Thymus capitatus extract in vitro. Phytother Res. 2018;32:1555\u201363. https:\/\/doi.org\/10.1002\/ptr.6084.","journal-title":"Phytother Res"},{"key":"5556_CR23","doi-asserted-by":"publisher","first-page":"1636","DOI":"10.1055\/s-0032-1315208","volume":"78","author":"WL Lai","year":"2012","unstructured":"Lai WL, Chuang HS, Lee MH. Inhibition of herpes simplex virus type 1 by thymol-related monoterpenoids. Planta Med. 2012;78:1636\u20138. https:\/\/doi.org\/10.1055\/s-0032-1315208.","journal-title":"Planta Med"},{"key":"5556_CR24","doi-asserted-by":"publisher","first-page":"47","DOI":"10.1039\/A809656B","volume":"36","author":"I Munetaka","year":"1999","unstructured":"Munetaka I, Fumio O, Kazumi S, Tomoyuki H, Keiji S, Masami W. A water soluble Tetrazolium salt useful for colorimetric cell viability assay. Anal Commun. 1999;36:47\u201350. https:\/\/doi.org\/10.1039\/A809656B.","journal-title":"Anal Commun"},{"key":"5556_CR25","doi-asserted-by":"publisher","first-page":"62","DOI":"10.1016\/j.antiviral.2008.01.156","volume":"79","author":"CT Su","year":"2008","unstructured":"Su CT, Hsu TA, Hsieh HP, Lin PH, Chen TC, Kao CL, et al. Anti-HSV activity of digitoxin and its possible mechanisms. Antivir Res. 2008;79:62\u20137. https:\/\/doi.org\/10.1016\/j.antiviral.2008.01.156.","journal-title":"Antivir Res"},{"key":"5556_CR26","doi-asserted-by":"publisher","first-page":"68","DOI":"10.1016\/j.antiviral.2006.03.017","volume":"72","author":"H Zhen","year":"2006","unstructured":"Zhen H, Fang F, Ye DY. Experimental study on the action of allitridin against human cytomegalovirus in vitro: inhibitory effects on immediate-early genes. Antivir Res. 2006;72:68\u201374. https:\/\/doi.org\/10.1016\/j.antiviral.2006.03.017.","journal-title":"Antivir Res"},{"key":"5556_CR27","doi-asserted-by":"publisher","first-page":"e2749","DOI":"10.1038\/cddis.2017.139","volume":"8","author":"Y You","year":"2017","unstructured":"You Y, Cheng AC, Wang MS. The suppression of apoptosis by \u03b1-herpesvirus. Cell Death Dis. 2017;8:e2749\u201360. https:\/\/doi.org\/10.1038\/cddis.2017.139.","journal-title":"Cell Death Dis"},{"key":"5556_CR28","doi-asserted-by":"publisher","first-page":"796","DOI":"10.1128\/JVI.55.3.796-805.1985","volume":"55","author":"WR Sacks","year":"1985","unstructured":"Sacks WR, Greene CC, Aschman DP. Herpes simplex virus type 1 ICP27 is an essential regulatory protein. J Virol. 1985;55:796\u2013805 PMCID: PMC255064.","journal-title":"J Virol"},{"key":"5556_CR29","doi-asserted-by":"publisher","first-page":"7084","DOI":"10.1128\/JVI.00463-12","volume":"86","author":"RM Mingo","year":"2012","unstructured":"Mingo RM, Han J, Newcomb WW, Brown JC. Replication of herpes simplex virus: egress of progeny virus at specialized cell membrane sites. J Virol. 2012;86:7084\u201397. https:\/\/doi.org\/10.1128\/JVI.00463-12.","journal-title":"J Virol"},{"key":"5556_CR30","doi-asserted-by":"publisher","first-page":"3675","DOI":"10.1128\/JVI.75.8.3675-3684.2001","volume":"75","author":"H Granzow","year":"2001","unstructured":"Granzow H, Klupp BG, Fuchs W, Veits J, Osterrieder N, Mettenleiter TC. Egress of alphaherpesviruses: comparative ultrastructural study. J Virol. 2001;75:3675\u201384. https:\/\/doi.org\/10.1128\/JVI.75.8.3675-3684.2001.","journal-title":"J Virol"},{"key":"5556_CR31","doi-asserted-by":"publisher","first-page":"5084","DOI":"10.3390\/v7092861","volume":"7","author":"DJ Owen","year":"2015","unstructured":"Owen DJ, Crump CM, Graham SC. Tegument assembly and secondary envelopment of Alphaherpesviruses. Viruses. 2015;7:5084\u2013114. https:\/\/doi.org\/10.3390\/v7092861.","journal-title":"Viruses"},{"key":"5556_CR32","doi-asserted-by":"publisher","first-page":"840","DOI":"10.4014\/jmb.1712.12052","volume":"28","author":"D Wenwen","year":"2018","unstructured":"Wenwen D, Yu W, Jinpeng B, Jingyu W, Shuai W, Wei K. Antiviral effect of Retro-2.1 against herpes simplex virus type 2 in vitro. J Microbiol Biotechnol. 2018;28:840\u201359. https:\/\/doi.org\/10.4014\/jmb.1712.12052.","journal-title":"J Microbiol Biotechnol"},{"key":"5556_CR33","first-page":"24","volume-title":"The mechanism of anti-herpes simplex virus (HSV) effect of zinc Ionophore and preliminary study of the relationship between ubiquitin-proteasome pathway and HSV replication [PhD thesis]","author":"M Qiu","year":"2014","unstructured":"Qiu M, Wu ZW. The mechanism of anti-herpes simplex virus (HSV) effect of zinc Ionophore and preliminary study of the relationship between ubiquitin-proteasome pathway and HSV replication [PhD thesis]. Nanjing: Nanjing University; 2014. p. 24\u201341."},{"key":"5556_CR34","doi-asserted-by":"publisher","first-page":"241","DOI":"10.2741\/a129","volume":"1","author":"FJ Jenkins","year":"1996","unstructured":"Jenkins FJ, Turner SL. Herpes simplex virus: a tool for neuroscientists. Front Biosci. 1996;1:241\u20137. https:\/\/doi.org\/10.2741\/a129.","journal-title":"Front Biosci"},{"key":"5556_CR35","doi-asserted-by":"publisher","first-page":"1969","DOI":"10.1128\/JVI.70.3.1969-1980.1996","volume":"70","author":"SL Uprichard","year":"1996","unstructured":"Uprichard SL, Knipe DM. Herpes simplex ICP27 mutant viruses exhibit reduced expression of specific DNA replication genes. J Virol. 1996;70:1969\u201380 PMCID:PMC190026.","journal-title":"J Virol"},{"key":"5556_CR36","doi-asserted-by":"publisher","first-page":"1063","DOI":"10.1128\/jvi.78.3.1063-1068.2004","volume":"78","author":"JR Smiley","year":"2004","unstructured":"Smiley JR. Herpes simplex virus virion host shutoff protein: immune evasion mediated by a viral RNase? J Virol. 2004;78:1063\u20138. https:\/\/doi.org\/10.1128\/jvi.78.3.1063-1068.2004.","journal-title":"J Virol"},{"key":"5556_CR37","doi-asserted-by":"publisher","first-page":"a013011","DOI":"10.1101\/cshperspect.a013011","volume":"4","author":"SK Weller","year":"2012","unstructured":"Weller SK, Coen DM. Herpes simplex viruses: mechanisms of DNA replication. Cold Spring Harb Perspect Biol. 2012;4:a013011. https:\/\/doi.org\/10.1101\/cshperspect.a013011.","journal-title":"Cold Spring Harb Perspect Biol"},{"key":"5556_CR38","doi-asserted-by":"publisher","first-page":"77","DOI":"10.1186\/s12985-016-0528-0","volume":"13","author":"Y Xiaoliang","year":"2016","unstructured":"Xiaoliang Y, Sudan H. The interplay between human herpes simplex virus infection and the apoptosis and necroptosis cell death pathways. Viol J. 2016;13:77\u201384. https:\/\/doi.org\/10.1186\/s12985-016-0528-0.","journal-title":"Viol J"},{"key":"5556_CR39","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1007\/s13365-014-0306-y","volume":"21","author":"PGE Kennedy","year":"2015","unstructured":"Kennedy PGE. Viruses, apoptosis, and neuroinflammation - a double-edged sword. J Neuro-Oncol. 2015;21:1\u20137. https:\/\/doi.org\/10.1007\/s13365-014-0306-y.","journal-title":"J Neuro-Oncol"},{"key":"5556_CR40","doi-asserted-by":"publisher","first-page":"373","DOI":"10.1152\/physrev.00027.2001","volume":"82","author":"MH Glickman","year":"2002","unstructured":"Glickman MH, Ciechanover A. The ubiquitin-proteasome proteolytic pathy: destruction for the sake of construction. Physiol Rev. 2002;82:373\u2013428. https:\/\/doi.org\/10.1152\/physrev.00027.2001.","journal-title":"Physiol Rev"},{"key":"5556_CR41","doi-asserted-by":"publisher","first-page":"8","DOI":"10.1007\/s13365-014-0302-2","volume":"21","author":"CM Kollias","year":"2015","unstructured":"Kollias CM, Huneke RB, Wigdahl B, Jennings SR. Animal models of herpes simplex virus immunity and pathogenesis. J Neuro-Oncol. 2015;21:8\u201323. https:\/\/doi.org\/10.1007\/s13365-014-0302-2.","journal-title":"J Neuro-Oncol"},{"key":"5556_CR42","doi-asserted-by":"publisher","first-page":"1049","DOI":"10.1095\/biolreprod.107.063933","volume":"77","author":"EM MacDonald","year":"2007","unstructured":"MacDonald EM, Savoy A, Gillgrass A, Fernandez S, Smieja M, Rosenthal KL, et al. Susceptibility of human female primary genital epithelial cells to herpes simplex virus, type-2 and the effect of TLR3 ligand and sex hormones on infection. Biol Reprod. 2007;77:1049\u201359. https:\/\/doi.org\/10.1095\/biolreprod.107.063933.","journal-title":"Biol Reprod"}],"container-title":["BMC Infectious Diseases"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12879-020-05556-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1186\/s12879-020-05556-9\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12879-020-05556-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,11,11]],"date-time":"2020-11-11T13:04:07Z","timestamp":1605099847000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcinfectdis.biomedcentral.com\/articles\/10.1186\/s12879-020-05556-9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,11,11]]},"references-count":42,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2020,12]]}},"alternative-id":["5556"],"URL":"https:\/\/doi.org\/10.1186\/s12879-020-05556-9","relation":{},"ISSN":["1471-2334"],"issn-type":[{"value":"1471-2334","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,11,11]]},"assertion":[{"value":"3 June 2020","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"28 October 2020","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"11 November 2020","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Cell and virus were studied so there was no ethics issue on this paper.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare that they have no competing interests.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"832"}}